Form 4/A for CCCC C4 Therapeutics, Inc.
Accepted 2022-06-14 00:00:00 ET · period of report 2022-05-26 · accession 0001209191-22-036716 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2022-06-14 | 2022-05-26 | CCCC | Hirsch Andrew | Pres, CEO, Dir | F - Tax | $7.01 | -3,675 | 18.8K | -16% | -$25.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-26 | F | D | 3,675 | $7.01 | 18,825 | D | — | — |